Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

cardiologists heart doctors

Early TAVR or SAVR in asymptomatic patients linked to improved survival, reduced costs

Researchers explored data from more than 24,000 AVR patients, presenting their findings at EuroPCR in Paris.

Video interview with Gregg Fonarow, MD, explaining the success of the AHA Get With The Guidelines-Stroke program, during AHA 2024.

Stroke care continues to evolve thanks to AI, cardiologists and more

Gregg Fonarow, MD, discussed the American Heart Association's stroke guidelines, the growing influence of AI and much more.

Medtronic Evolut FX TAVR valve

Medtronic gains a key approval for Evolut TAVR valves

More patients can now undergo redo TAVR with a Medtronic valve than ever before.

The Shockwave Medical M5+ new peripheral intravascular lithotripsy (IVL) catheter cuts procedures times in half and was showed for the first time at the American College of Cardiology (ACC) 2022 meeting. It is designed to break up calcium in heavily calcified arteries to avoid the need for vessel trauma caused by high pressure angioplasty.

IVL delivers significant value for women, real-world data confirm

Researchers tracked data from nearly 400 women with complex CAD who underwent treatment with Shockwave Medical's intravascular lithotripsy technology prior to PCI.

Thumbnail

Same-day discharge after TAVR linked to positive outcomes

When low-risk patients undergo transfemoral TAVR, they may be able to go home without spending a single night at the hospital.

robotic PCI Corindus CorPath GRX

Robotic PCI confirmed to be both safe and effective in new comprehensive analysis

Researchers reviewed years of data from two different Corindus systems, highlighting the consistently high clinical and technical success rates.

Edwards Lifesciences SAPIEN 3 Ultra TAVR valve

Intra-annular TAVR valves from Edwards Lifesciences and Abbott deliver similar 1-year outcomes

Each valve was associated with certain benefits, but one-year outcomes were largely similar. 

PCI interventional cardiology

PCI just as successful when patients have a history of TAVR—but there are some added risks

Strokes and bleeding complications are more likely when PCI patients have already undergone TAVR, according to a new analysis of ACC registry data.